摘要
Future Medicinal ChemistryVol. 9, No. 1 CommentaryWhy we need to implement intramolecular hydrogen-bonding considerations in drug discoveryGiulia Caron & Giuseppe ErmondiGiulia Caron*Author for correspondence: E-mail Address: giulia.caron@unito.it Department of Molecular Biotechnology & Health Sciences, University of Torino, Via Quarello, 15, 10135-Torino, ItalySearch for more papers by this author & Giuseppe Ermondi Department of Molecular Biotechnology & Health Sciences, University of Torino, Via Quarello, 15, 10135-Torino, ItalySearch for more papers by this authorPublished Online:13 Dec 2016https://doi.org/10.4155/fmc-2016-0195AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: ADME-Toxdrug designdrug discoveryintramolecular hydrogen bondintramolecular hydrogen bond propensityReferences1 Castellano R. Special issue: intramolecular hydrogen bonding. Molecules 19(10), 15783–15785 (2014).Crossref, Medline, CAS, Google Scholar2 EFMC-ISMC 2016 – XXIV EFMC International Symposium on Medicinal Chemistry. http://www.ldorganisation.com/v2/produits.php?langue=english&cle_menus=1238915829.Google Scholar3 Steyaert G, Pagliara A, Crivori P et al. Structure–lipophilicity relationships of neutral and protonated β-blockers. Helv. Chim. Acta. 82, 1211–1222 (1999).Crossref, Google Scholar4 Caron G, Ermondi G, Damiano A et al. Ionization, lipophilicity, and molecular modeling to investigate permeability and other biological properties of amlodipine. Bioorg. Med. Chem. 12, 6107–6118 (2004).Crossref, Medline, CAS, Google Scholar5 Rey S, Caron G, Ermondi G et al. Development of molecular hydrogen-bonding potentials (MHBPs) and their application to structure-permeation relations. J. Mol. Graph. Model. 19(6), 521–535, 594–597 (2001).Crossref, Medline, CAS, Google Scholar6 Doak BC, Over B, Giordanetto F, Kihlberg J. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem. Biol. 21(9), 1115–1142 (2014).Crossref, Medline, CAS, Google Scholar7 Gleeson MP, Hersey A, Montanari D, Overington J. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat. Rev. Drug Discov. 10(3), 197–208 (2011).Crossref, Medline, CAS, Google Scholar8 Leeson PD, Young RJ. Molecular property design: does everyone get it? ACS Med. Chem. Lett. 6(7), 722–725 (2015).Crossref, Medline, CAS, Google Scholar9 Bilton C, Allen FH, Shields GP, Howard JA. Intramolecular hydrogen bonds: common motifs, probabilities of formation and implications for supramolecular organization research papers. Acta Crystallogr. B56, 849–856 (2000).Crossref, CAS, Google Scholar10 Kuhn B, Mohr P, Stahl M. Intramolecular hydrogen bonding in medicinal chemistry. J. Med. Chem. 53(6), 2601–2611 (2010).Crossref, Medline, CAS, Google Scholar11 Alex A, Millan DS, Perez M et al. Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space. MedChemComm 2(7), 669 (2011).Crossref, CAS, Google Scholar12 Surade S, Blundell TL. Structural biology and drug discovery of difficult targets: the limits of ligandability. Chem. Biol. 19(1), 42–50 (2012).Crossref, Medline, CAS, Google Scholar13 Ashwood VA, Field MJ, Horwell DC et al. Penetration of an NK 1 receptor antagonist. J. Med. Chem. 44, 2276–2285 (2001).Crossref, Medline, CAS, Google Scholar14 Palm K, Stenberg P, Luthman K, Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14(5), 568–571 (1997).Crossref, Medline, CAS, Google Scholar15 Waring MJ. Defining optimum lipophilicity and molecular weight ranges for drug candidates – molecular weight dependent lower log D limits based on permeability. Bioorganic Med. Chem. Lett. 19(10), 2844–2851 (2009).Crossref, Medline, CAS, Google Scholar16 Potter T, Ermondi G, Newbury G et al. Relating Caco-2 permeability to molecular properties using Block Relevance analysis. MedChemComm 6, 626–629 (2014).Crossref, Google Scholar17 Ermondi G, Caron G. Molecular interaction fields based descriptors to interpret and compare chromatographic indexes. J. Chromatogr. A 1252, 84–89 (2012).Crossref, Medline, CAS, Google Scholar18 Caron G, Vallaro M, Ermondi G. The Block Relevance (BR) analysis to aid medicinal chemists to determine and interpret lipophilicity. MedChemComm 4(10), 1376 (2013).Crossref, CAS, Google Scholar19 Wang CK, Northfield SE, Swedberg JE et al. Exploring experimental and computational markers of cyclic peptides: charting islands of permeability. Eur. J. Med. Chem. 97, 202–213 (2015).Crossref, Medline, CAS, Google Scholar20 Hewitt WM, Leung SSF, Pye CR et al. Cell-permeable cyclic peptides from synthetic libraries inspired by natural products. J. Am. Chem. Soc. 137(2), 715–721 (2015).Crossref, Medline, CAS, Google Scholar21 Witek J, Keller BG, Blatter M, Meissner A, Wagner T, Riniker S. Kinetic models of cyclosporin A in polar and apolar environments reveal multiple congruent conformational states. J. Chem. Inf. Model. 56(8), 1547–1562 (2016).Crossref, Medline, CAS, Google Scholar22 Tardia P, Stefanachi A, Niso M et al. Trimethoxybenzanilide-based p-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding. J. Med. Chem. 57(15), 6403–6418 (2014).Crossref, Medline, CAS, Google Scholar23 Shalaeva M, Caron G, Abramov YA et al. Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using Δ logP as a tool. J. Med. Chem. 56(12), 4870–4879 (2013).Crossref, Medline, CAS, Google Scholar24 Goetz GH, Farrell W, Shalaeva M et al. High throughput method for the indirect detection of intramolecular hydrogen bonding. J. Med. Chem. 57(7), 2920–2929 (2014).Crossref, Medline, CAS, Google Scholar25 Caron G, Vallaro M, Ermondi G et al. A fast chromatographic method for estimating lipophilicity and ionization in nonpolar membrane-like environment. Mol. Pharm. 13(3), 1100–1110 (2016).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByRecognition and release of uridine and hCNT3: From multivariate interactions to molecular designInternational Journal of Biological Macromolecules, Vol. 223Synthesis of magnetic nanoparticles Fe3O4@CQD@Si(OEt)(CH2)3@melamine@TC@Ni(NO3) with application in the synthesis of 2-amino-3-cyanopyridine and pyrano[2,3-c]pyrazole derivatives28 March 2022 | Research on Chemical Intermediates, Vol. 48, No. 6Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, Vol. 222In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductaseSaudi Journal of Biological Sciences, Vol. 28, No. 1Predicting the Limit of Intramolecular Hydrogen Bonding with Classical Molecular Dynamics14 February 2019 | Angewandte Chemie, Vol. 131, No. 12Predicting the Limit of Intramolecular Hydrogen Bonding with Classical Molecular DynamicsAngewandte Chemie International Edition, Vol. 58, No. 12High throughput methods to measure the propensity of compounds to form intramolecular hydrogen bonding1 January 2017 | MedChemComm, Vol. 8, No. 6 Vol. 9, No. 1 Follow us on social media for the latest updates Metrics Downloaded 287 times History Published online 13 December 2016 Published in print January 2017 Information© Future Science LtdKeywordsADME-Toxdrug designdrug discoveryintramolecular hydrogen bondintramolecular hydrogen bond propensityFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download